Company: BGLC
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003821
Chunk: 23

Company: BioNexus Gene Lab Corp
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
2025  2024 Investment in equity securities with readily determined fair value:      Malaysia  808,303   863,810 Singapore  179,302   177,808   $987,605  $1,041,618 Investment in equity securities without readily determined fair value:        Malaysia  225,743   223,548   $1,213,348  $1,265,166  The Company’s investment in equity securities is measured at fair value on a recurring basis. These equity securities are classified as Level 1 in the fair value hierarchy, as the fair value is determined using quoted market prices in active markets for identical assets. Specifically, the stock prices of these securities are readily available on the stock exchange, providing a reliable and observable input to the fair value measurement. As these securities are actively traded, the quoted prices in the market are considered to be the most reliable indicator of fair value. No significant adjustments are made to these prices, as they reflect current market conditions at the measurement date.

NOTE 8 - TRADE PAYABLES Trade payables are amounts billed to the Company by suppliers for goods and services in the ordinary course of business. All amounts have short-term repayment terms and vary by supplier.

 20Table of Contents

BIONEXUS GENE LAB CORP. 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 

FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024 

(Currency expressed in United States Dollars (“US$”)) 

(Unaudited)

NOTE 9 – REVENUE  The following table shows disaggregated net revenue from contracts with customers by product or service line and geographic area for the period ended March 31, 2025 and 2024:    Three months ended    March 31,  March 31,   2025  2024 Revenue by product or service line:      Trading of industrial chemicals  2,134,007   2,378,686 Screening services and related sales  3,068   3,165  Net revenue  $2,137,075  $2,381,851          Revenue by geographic area        Bangladesh  -   147,287 Malaysia  1,747,528